CYTOKINE PROFILE IN QUADRICEPS MUSCLES OF PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

ROS, reactive oxygen species; NADPH, nicotinamide adenine dinucleotide phosphate. ABSTRACT Background: Systemic proinflammatory cytokines and oxidative stress have been described in association with peripheral muscle wasting and weakness of patients with severe chronic obstructive pulmonary disease (COPD), but their expression in skeletal muscle is unknown. Objectives of the present study were to determine muscle protein levels of selected cytokines in patients with COPD and to study their relationships with protein carbonylation as a marker of oxidative stress, quadriceps function, and exercise capacity. Methods: We conducted a cross-sectional study in which 36 cytokines were detected using a human antibody array in quadriceps specimens obtained from 19 patients with severe COPD and 7 healthy controls. Subsequently, selected cytokines [tumor necrosis factor (TNF)-alpha, TNF-alpha receptors I and II, interleukin (IL)-6, interferon-gamma, transforming growth factor (TGF)-beta, and vascular endothelial growth factor (VEGF)], as well as protein carbonylation (oxidative stress index) were determined using enzyme-linked immunosorbent assay (ELISA) in all muscles. Results: As compared to controls, vastus lateralis of COPD patients showed significantly lower protein ELISA levels of TNF-alpha, which positively correlated with their quadriceps function, TNF-alpha receptor II, and VEGF. Protein ELISA levels of IL-6, interferon-gamma, and TGF-beta did not differ between patients and controls. Quadriceps protein carbonylation was greater in the patients and inversely correlated with quadriceps strength amongst them. Conclusions: These findings do not support the presence of a pro-inflammatory environment within the quadriceps muscles of clinically and weight stable patients with severe COPD, despite evidence for increased oxidative stress and the presence of muscle weakness.

[1]  E. Barreiro,et al.  Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients , 2007, European Respiratory Journal.

[2]  S. Hussain,et al.  Ventilatory muscle activation and inflammation: cytokines, reactive oxygen species, and nitric oxide. , 2007, Journal of applied physiology.

[3]  J. Viña,et al.  Exercise-induced systemic effects in muscle-wasted patients with COPD. , 2006, Medicine and science in sports and exercise.

[4]  S. Hussain,et al.  Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. , 2005, American journal of respiratory cell and molecular biology.

[5]  J. D. de Sanctis,et al.  Skeletal muscle inflammation and nitric oxide in patients with COPD , 2005, European Respiratory Journal.

[6]  F. Maltais,et al.  Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease , 2005, Thorax.

[7]  F. Maltais,et al.  Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[8]  S. Hussain,et al.  Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[9]  E. Hawe,et al.  Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[10]  G. Rallis,et al.  Differential cytokine gene expression in the diaphragm in response to strenuous resistive breathing. , 2004, American journal of respiratory and critical care medicine.

[11]  J. Gea,et al.  Relevance of assessing quadriceps endurance in patients with COPD , 2004, European Respiratory Journal.

[12]  P. Chanez,et al.  Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? , 2004, European Respiratory Journal.

[13]  E. Wouters,et al.  Tumor necrosis factor‐alpha inhibits myogenic differentiation through MyoD protein destabilization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  E. Wouters,et al.  Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[15]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[16]  J. Barberà,et al.  Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients , 2003, European Respiratory Journal.

[17]  Ruo-Pan Huang,et al.  Detection of Multiple Cytokines by Protein Arrays from Cell Lysate and Tissue Lysate , 2003, Clinical chemistry and laboratory medicine.

[18]  Yi-Ping Li TNF-alpha is a mitogen in skeletal muscle. , 2003, American journal of physiology. Cell physiology.

[19]  F. Maltais,et al.  Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in COPD patients , 2003 .

[20]  M. Luster,et al.  Physiological role of tumor necrosis factor α in traumatic muscle injury , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  P. Blackshear,et al.  Load-Dependent and -Independent Regulation of Proinflammatory Cytokine and Cytokine Receptor Gene Expression in the Adult Mammalian Heart , 2002, Circulation.

[22]  Sally J. Singh,et al.  Bedside methods versus dual energy X‐ray absorptiometry for body composition measurement in COPD , 2002, European Respiratory Journal.

[23]  F. Maltais,et al.  Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease , 2002, Muscle & nerve.

[24]  E. Wouters,et al.  Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. , 2002, American journal of physiology. Cell physiology.

[25]  J. Barberà,et al.  Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[26]  R. Huang,et al.  Detection of multiple proteins in an antibody-based protein microarray system. , 2001, Journal of immunological methods.

[27]  X. Busquets,et al.  Enhanced neutrophil response in chronic obstructive pulmonary disease , 2001, Thorax.

[28]  Yi-Ping Li,et al.  Cytokines and oxidative signalling in skeletal muscle. , 2001, Acta physiologica Scandinavica.

[29]  A. Agustí,et al.  The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis. , 2000, American journal of respiratory and critical care medicine.

[30]  H. Saito,et al.  The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[31]  E. Wouters,et al.  Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. , 2000, American journal of respiratory and critical care medicine.

[32]  N. Hopkinson,et al.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. , 2009, American journal of respiratory and critical care medicine.

[33]  H. Saito,et al.  Circulating leptin in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[34]  F. Maltais,et al.  Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. , 1998, Journal of cardiopulmonary rehabilitation.

[35]  F. Maltais,et al.  Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.

[36]  F. Maltais,et al.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[37]  E. Wouters,et al.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.

[38]  M. Decramer,et al.  Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.

[39]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[40]  E. Stadtman,et al.  Carbonyl assays for determination of oxidatively modified proteins. , 1994, Methods in enzymology.

[41]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[42]  L. Makrides,et al.  Normal standards for an incremental progressive cycle ergometer test. , 1985, The American review of respiratory disease.